Real-world delivery rate to third-line chemotherapy in patients with advanced gastric cancer

被引：0
|
作者：
Ueno, Masayuki [1 ]
Doi, Akira [1 ]
Mouri, Hirokazu [1 ]
Yamamoto, Hiroshi [1 ]
Mizuno, Motowo [1 ]
机构：
[1] Kurashiki Cent Hosp, Dept Gastroenterol & Hepatol, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2 - 062
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of Clinical Response to First-Line Chemotherapy on Gastric Cancer Patients Treated with Second-Line and Third-Line Chemotherapy
    Kodera, Yasuhiro
    Ito, Yuichi
    Ohashi, Norifumi
    Nakayama, Goro
    Koike, Masahiko
    Fujiwara, Michitaka
    Nakao, Akimasa
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 1041 - 1045
  • [32] Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer
    Talwar, Vineet
    Raina, Shubhra
    Goel, Varun
    Dash, Prasanta
    Doval, Dinesh C.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (05) : 475 - 481
  • [33] Identification of patients with advanced pancreatic cancer who might benefit from third-line chemotherapy
    Kim, Bomi
    Kim, Jaihwan
    Yang, Soomin
    Ahn, Jinwoo
    Jung, Kwangrok
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [34] Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
    Deng, Ting
    Duan, Jingjing
    Bai, Ming
    Zhang, Le
    Li, Hongli
    Liu, Rui
    Ning, Tao
    Ge, Shaohua
    Wang, Xia
    Yang, Yuchong
    Ji, Zhi
    Wang, Feixue
    Ba, Yi
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [35] Does neoadjuvant chemotherapy increase the survival in patients with locally advanced gastric cancer patients? - A real-world evidence
    Janarthinakani, Murugesan
    Kalaiselvi, Selvaraj
    Priyadarshini, Rajamani
    Arun, Seshachalam
    Shashidhar, K.
    Krishnakumar, R.
    Manjunath, N.
    Roopa, Sirigeri
    Raman, S. G.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (06) : 832 - 840
  • [36] Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer
    Liu, Liya
    Yu, Hao
    Huang, Lihong
    Shao, Fang
    Bai, Jianling
    Lou, Donghua
    Chen, Feng
    OncoTargets and Therapy, 2015, 8 : 921 - 928
  • [37] Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer A Retrospective Cohort Study
    Ogata, Takatsugu
    Narita, Yukiya
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Matsubara, Yuki
    Kato, Kyoko
    Nozawa, Kazuki
    Honda, Kazunori
    Masuishi, Toshiki
    Bando, Hideaki
    Kadowaki, Shigenori
    Ando, Masashi
    Tajika, Masahiro
    Muro, Kei
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (08): : 388 - 394
  • [38] Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer
    Celik, Alan
    Berg, Tobias
    Jensen, Maj-Britt
    Jakobsen, Erik
    Nielsen, Hanne Melgaard
    Kumler, Iben
    Glavicic, Vesna
    Jensen, Jeanette Dupont
    Knoop, Ann
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2023, 17
  • [39] Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
    Reibel, J. B.
    Hubbard, R.
    Sun, L.
    Parikh, R. B.
    Martin, L. P.
    Mamtani, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S942 - S943
  • [40] Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study
    Jingjing Duan
    Lila Zhu
    Yinghui Shi
    Weixue Wang
    Tongtong Wang
    Tao Ning
    Le Zhang
    Ming Bai
    Hongli Li
    Rui Liu
    Shaohua Ge
    Xia Wang
    Yuchong Yang
    Zhi Ji
    Feixue Wang
    Yansha Sun
    Yi Ba
    Ting Deng
    BMC Cancer, 24
12345